QuantiFERON® -TB Gold
Malaysian Health Technology Assessment (MaHTAS)
Record ID 32016000505
English
Authors' objectives:
To review evidence on the efficacy, safety and cost-effectiveness of QuantiFERON® -TB Gold as diagnostic tools for detection of patient with LTBI and active TB.
Authors' recommendations:
QuantiFERON® -TB Gold (QFT) appeared to have numerous advantages over TST such as higher specificity, PPV and NPV in adult population in low TB prevalence countries, better relationship with M. tuberculosis exposure, and lower cross-reaction rates with BCG vaccination and NTM. There was also evidence to suggest that QFT-alone was likely to be more costly but more effective than TST in Japan and United States.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.moh.gov.my/index.php/database_stores/store_view_page/30/216
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Malaysia
MeSH Terms
- Humans
- Mycobacterium tuberculosis
- Japan
- United States
- Vaccination
- Tuberculin Test
- Adult
Contact
Organisation Name:
Malaysian Health Technology Assessment
Contact Address:
Malaysian Health Technology Assessment Section, Ministry of Health Malaysia, Federal Government Administrative Centre, Level 4, Block E1, Parcel E, 62590 Putrajaya Malaysia Tel: +603 8883 1229
Contact Name:
htamalaysia@moh.gov.my
Contact Email:
htamalaysia@moh.gov.my
Copyright:
Malaysian Health Technology Assessment (MaHTAS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.